Nano‐Graphene Oxide: A Potential Multifunctional Platform for Cancer Therapy

Nano-GO is a graphene derivative with a 2D atomic layer of sp² bonded carbon atoms in hexagonal conformation together with sp³ domains with carbon atoms linked to oxygen functional groups. The supremacy of nano-GO resides essentially in its own intrinsic chemical and physical structure, which confers an extraordinary chemical versatility, high aspect ratio and unusual physical properties. The chemical versatility of nano-GO arises from the oxygen functional groups on the carbon structure that make possible its relatively easy functionalization, under mild conditions, with organic molecules or biological structures in covalent or non-covalent linkage. The synergistic effects resulting from the assembly of well-defined structures at nano-GO surface, in addition to its intrinsic optical, mechanical and electronic properties, allow the development of new multifunctional hybrid materials with a high potential in multimodal cancer therapy. Herein, a comprehensive review of the fundamental properties of nano-GO requirements for cancer therapy and the first developments of nano-GO as a platform for this purpose is presented.

[1]  R. Ruoff,et al.  Chemical methods for the production of graphenes. , 2009, Nature nanotechnology.

[2]  Chun-Wei Chen,et al.  Blue photoluminescence from chemically derived graphene oxide. , 2010, Advanced materials.

[3]  Liangzhu Feng,et al.  Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. , 2011, ACS nano.

[4]  Maneerat Ekkapongpisit,et al.  Biocompatibility, endocytosis, and intracellular trafficking of mesoporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups , 2012, International journal of nanomedicine.

[5]  R. Ruoff,et al.  Graphene and Graphene Oxide: Synthesis, Properties, and Applications , 2010, Advanced materials.

[6]  Vladimir Torchilin,et al.  Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.

[7]  Arben Merkoçi,et al.  Graphene Oxide as an Optical Biosensing Platform , 2012, Advanced materials.

[8]  Kai Yang,et al.  Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. , 2010, Nano letters.

[9]  K. Müllen,et al.  Bottom-up fabrication of photoluminescent graphene quantum dots with uniform morphology. , 2011, Journal of the American Chemical Society.

[10]  Gold nanoshells in cancer imaging and therapy: towards clinical application. , 2007, Nanomedicine.

[11]  Jie Huang,et al.  Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector , 2011 .

[12]  Fang Liu,et al.  Strongly green-photoluminescent graphene quantum dots for bioimaging applications. , 2011, Chemical communications.

[13]  J. DeSimone,et al.  Microfabricated Particles for Engineered Drug Therapies: Elucidation into the Mechanisms of Cellular Internalization of PRINT Particles , 2008, Pharmaceutical Research.

[14]  Shumeng Liu,et al.  Engineered polyethylenimine/graphene oxide nanocomposite for nuclear localized gene delivery , 2012 .

[15]  Michel Mermoux,et al.  FTIR and 13C NMR study of graphite oxide , 1991 .

[16]  Mi-Hee Kim,et al.  Behaviors of NIH-3T3 fibroblasts on graphene/carbon nanotubes: proliferation, focal adhesion, and gene transfection studies. , 2010, ACS nano.

[17]  Wolfgang J. Parak,et al.  Cellular toxicity of inorganic nanoparticles: Common aspects and guidelines for improved nanotoxicity evaluation , 2011 .

[18]  Chunhai Fan,et al.  Intracellular imaging with a graphene-based fluorescent probe. , 2010, Small.

[19]  Berk,et al.  Scale-invariant behavior and vascular network formation in normal and tumor tissue. , 1995, Physical review letters.

[20]  I. Aksay,et al.  Factors controlling the size of graphene oxide sheets produced via the graphite oxide route. , 2011, ACS nano.

[21]  Il-Kwon Oh,et al.  Graphene oxide-polyethylenimine nanoconstruct as a gene delivery vector and bioimaging tool. , 2011, Bioconjugate chemistry.

[22]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[23]  Warren C W Chan,et al.  The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.

[24]  Zhijun Zhang,et al.  Composites of aminodextran-coated Fe3O4 nanoparticles and graphene oxide for cellular magnetic resonance imaging. , 2011, ACS applied materials & interfaces.

[25]  Warren C W Chan,et al.  Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.

[26]  Charalambos Kaittanis,et al.  Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. , 2010, ACS nano.

[27]  Zhang Xiao,et al.  Cell Biocompatibility of Functionalized Graphene Oxide , 2012 .

[28]  L. Huang,et al.  Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. , 1992, Biochimica et biophysica acta.

[29]  Y. Chabal,et al.  Unusual infrared-absorption mechanism in thermally reduced graphene oxide. , 2010, Nature materials.

[30]  Yongsheng Chen,et al.  Superparamagnetic graphene oxide–Fe3O4nanoparticles hybrid for controlled targeted drug carriers , 2009 .

[31]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Shouwu Guo,et al.  Folic Acid-conjugated Graphene Oxide loaded with Photosensitizers for Targeting Photodynamic Therapy , 2011, Theranostics.

[33]  R. Ruoff,et al.  The chemistry of graphene oxide. , 2010, Chemical Society reviews.

[34]  S. Stankovich,et al.  Synthesis of graphene-based nanosheets via chemical reduction of exfoliated graphite oxide , 2007 .

[35]  Mingli Chen,et al.  Conjugation of quantum dots with graphene for fluorescence imaging of live cells. , 2011, The Analyst.

[36]  F. Fay,et al.  Antibody-targeted nanoparticles for cancer therapy. , 2011, Immunotherapy.

[37]  Michael Keidar,et al.  The large-scale production of graphene flakes using magnetically-enhanced arc discharge between carbon electrodes , 2010 .

[38]  Yuehe Lin,et al.  Graphene and graphene oxide: biofunctionalization and applications in biotechnology , 2011, Trends in Biotechnology.

[39]  Warren C W Chan,et al.  Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.

[40]  Dai Fukumura,et al.  Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in tumor vascular networks , 2010, Nature Methods.

[41]  Benjamin C. Tang,et al.  PEGylation of nanoparticles improves their cytoplasmic transport , 2007, International journal of nanomedicine.

[42]  He Shen,et al.  Biomedical Applications of Graphene , 2012, Theranostics.

[43]  R. Langer,et al.  Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis , 2005, The journal of gene medicine.

[44]  Cui Tang,et al.  Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.

[45]  Nicholas Melosh,et al.  Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation. , 2012, Nano letters.

[46]  J. Crain,et al.  Scattering and Interference in Epitaxial Graphene , 2007, Science.

[47]  F. Caruso,et al.  Challenges facing colloidal delivery systems: From synthesis to the clinic , 2011 .

[48]  Eun Sung Kim,et al.  Synthesis of Large‐Area Graphene Layers on Poly‐Nickel Substrate by Chemical Vapor Deposition: Wrinkle Formation , 2009 .

[49]  Wei Gao,et al.  New insights into the structure and reduction of graphite oxide. , 2009, Nature chemistry.

[50]  Scott E McNeil,et al.  Nanomaterial standards for efficacy and toxicity assessment. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[51]  N. Sugimoto,et al.  Detection of a Prognostic Indicator in Early‐Stage Cancer Using Functionalized Graphene‐Based Peptide Sensors , 2012, Advanced materials.

[52]  Xungai Wang,et al.  Graphene oxide nanoparticles as a nonbleaching optical probe for two-photon luminescence imaging and cell therapy. , 2012, Angewandte Chemie.

[53]  Hao Hong,et al.  In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene. , 2012, Biomaterials.

[54]  Mira Kim,et al.  A spatiotemporal anticancer drug release platform of PEGylated graphene oxide triggered by glutathione in vitro and in vivo , 2012 .

[55]  N. Sugimoto,et al.  Ultrasensitive and Selective Detection of a Prognostic Indicator in Early‐Stage Cancer Using Graphene Oxide and Carbon Nanotubes , 2010 .

[56]  J. Ahopelto,et al.  Interfacial engineering by proteins: exfoliation and functionalization of graphene by hydrophobins. , 2010, Angewandte Chemie.

[57]  Haiqing Dong,et al.  Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery. , 2012, Journal of biomedical materials research. Part A.

[58]  Wei Wei,et al.  The role of the lateral dimension of graphene oxide in the regulation of cellular responses. , 2012, Biomaterials.

[59]  C. Rao,et al.  Simple Method of Preparing Graphene Flakes by an Arc-Discharge Method , 2009 .

[60]  Feng Yan,et al.  The use of polyethylenimine-grafted graphene nanoribbon for cellular delivery of locked nucleic acid modified molecular beacon for recognition of microRNA. , 2011, Biomaterials.

[61]  Zhongpin Zhang,et al.  Highly efficient photoluminescent graphene oxide with tunable surface properties. , 2010, Chemical communications.

[62]  Li Wu,et al.  Label‐Free Ultrasensitive Detection of Human Telomerase Activity Using Porphyrin‐Functionalized Graphene and Electrochemiluminescence Technique , 2012, Advanced materials.

[63]  A. Reina,et al.  Large area, few-layer graphene films on arbitrary substrates by chemical vapor deposition. , 2009, Nano letters.

[64]  Kai Yang,et al.  Nano-graphene in biomedicine: theranostic applications. , 2013, Chemical Society reviews.

[65]  U. Nielsen,et al.  Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. , 2006, Cancer research.

[66]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[67]  Hui Jiang,et al.  Gold nanoclusters and graphene nanocomposites for drug delivery and imaging of cancer cells. , 2011, Angewandte Chemie.

[68]  Daniel A. Heller,et al.  Treating metastatic cancer with nanotechnology , 2011, Nature Reviews Cancer.

[69]  M. Singh,et al.  Graphene oxide modified with PMMA via ATRP as a reinforcement filler , 2010 .

[70]  Omid C Farokhzad,et al.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. , 2012, Chemical Society reviews.

[71]  A. Patil,et al.  Aqueous Stabilization and Self‐Assembly of Graphene Sheets into Layered Bio‐Nanocomposites using DNA , 2009 .

[72]  L. Zhang,et al.  Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.

[73]  Huang-Hao Yang,et al.  A graphene platform for sensing biomolecules. , 2009, Angewandte Chemie.

[74]  G. Eda,et al.  Tunable photoluminescence from graphene oxide. , 2012, Angewandte Chemie.

[75]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[76]  Triantafyllos Stylianopoulos,et al.  Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. , 2011, Annual review of chemical and biomolecular engineering.

[77]  R. Chen,et al.  TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis , 2008, Clinical Cancer Research.

[78]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[79]  Anna Moore,et al.  Magnetic Nanoparticles for Cancer Diagnosis and Therapy , 2012, Pharmaceutical Research.

[80]  X. Qu,et al.  New Horizons for Diagnostics and Therapeutic Applications of Graphene and Graphene Oxide , 2013, Advanced materials.

[81]  M Ferrari,et al.  Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[82]  Martin A. Cheever,et al.  The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research , 2009, Clinical Cancer Research.

[83]  Jesse V Jokerst,et al.  Nanoparticle PEGylation for imaging and therapy. , 2011, Nanomedicine.

[84]  Fangfang Guo,et al.  Poly(ethylene glycol) conjugated nano-graphene oxide for photodynamic therapy , 2010 .

[85]  Ashutosh Chilkoti,et al.  Nanomaterials for Drug Delivery , 2012, Science.

[86]  Marina A Dobrovolskaia,et al.  Nanoparticles and the immune system. , 2010, Endocrinology.

[87]  Lin Li,et al.  Water‐Soluble Poly(N‐isopropylacrylamide)–Graphene Sheets Synthesized via Click Chemistry for Drug Delivery , 2011 .

[88]  Kwang S. Kim,et al.  Large-scale pattern growth of graphene films for stretchable transparent electrodes , 2009, Nature.

[89]  Dan Peer,et al.  Nanoparticle hydrophobicity dictates immune response. , 2012, Journal of the American Chemical Society.

[90]  T. Ishida,et al.  Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes , 2010, Pharmaceutical Research.

[91]  Robert Langer,et al.  Targeted nanoparticles for cancer therapy , 2007 .

[92]  Sanjib Bhattacharyya,et al.  Inorganic Nanoparticles in Cancer Therapy , 2011, Pharmaceutical Research.

[93]  R. Jain,et al.  Can engineered bacteria help control cancer? , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[94]  Xin Yan,et al.  Synthesis of large, stable colloidal graphene quantum dots with tunable size. , 2010, Journal of the American Chemical Society.

[95]  Gil Gonçalves,et al.  The effects of graphene oxide nanosheets localized on F-actin filaments on cell-cycle alterations. , 2013, Biomaterials.

[96]  R. Weissleder A clearer vision for in vivo imaging , 2001, Nature Biotechnology.

[97]  Charles Li,et al.  Targeting Cancer Gene Therapy with Magnetic Nanoparticles , 2012, Oncotarget.

[98]  Mansoor M. Amiji,et al.  Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery , 2007, Pharmaceutical Research.

[99]  R. Jain,et al.  Role of extracellular matrix assembly in interstitial transport in solid tumors. , 2000, Cancer research.

[100]  J. Hubbell,et al.  Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages , 2012, International journal of nanomedicine.

[101]  I-Wei Chen,et al.  Quantum‐Dot‐Tagged Reduced Graphene Oxide Nanocomposites for Bright Fluorescence Bioimaging and Photothermal Therapy Monitored In Situ , 2012, Advanced materials.

[102]  Zhijun Zhang,et al.  Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. , 2010, Small.

[103]  J. Irudayaraj,et al.  Protein-directed reduction of graphene oxide and intracellular imaging. , 2011, Chemical communications.

[104]  Gert Storm,et al.  Gold nanoparticles in theranostic oncology: current state-of-the-art , 2012, Expert opinion on drug delivery.

[105]  Yang Xu,et al.  Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. , 2010, ACS nano.

[106]  Craig A. Poland,et al.  Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. , 2008, Nature nanotechnology.

[107]  Chunzhong Li,et al.  Facile preparation and upconversion luminescence of graphene quantum dots. , 2011, Chemical communications.

[108]  M. Hashida,et al.  Effect of Particle Size and Charge on the Disposition of Lipid Carriers After Intratumoral Injection into Tissue-isolated Tumors , 2004, Pharmaceutical Research.

[109]  Hua Yue,et al.  Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. , 2011, Biomacromolecules.

[110]  H. Dai,et al.  Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. , 2011, Journal of the American Chemical Society.

[111]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[112]  Kai Yang,et al.  In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. , 2012, ACS nano.

[113]  Chunhai Fan,et al.  Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration , 2011 .

[114]  Peng Chen,et al.  Interfacing live cells with nanocarbon substrates. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[115]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[116]  Zhuang Liu,et al.  PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. , 2008, Journal of the American Chemical Society.

[117]  Hao Hong,et al.  Graphene: a versatile nanoplatform for biomedical applications. , 2012, Nanoscale.

[118]  Bai-Shuan Liu,et al.  Peripheral nerve repair of transplanted undifferentiated adipose tissue-derived stem cells in a biodegradable reinforced nerve conduit. , 2012, Journal of biomedical materials research. Part A.

[119]  R. Skalak,et al.  Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery. , 1995, Cancer research.

[120]  Z. Marković,et al.  In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. , 2011, Biomaterials.

[121]  L. Brannon-Peppas,et al.  Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.

[122]  Yuan Ping,et al.  Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. , 2011, Small.

[123]  Kai Yang,et al.  The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. , 2012, Biomaterials.

[124]  Tal Dvir,et al.  Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin. , 2011, Biomaterials.

[125]  Vincent M. Rotello,et al.  Cell surface-based differentiation of cell types and cancer states using a gold nanoparticle-GFP based sensing array , 2010 .

[126]  Henrike Caysa,et al.  Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model. , 2011, ACS nano.

[127]  Ganesh Gollavelli,et al.  Multi-functional graphene as an in vitro and in vivo imaging probe. , 2012, Biomaterials.

[128]  Yanli Chang,et al.  In vitro toxicity evaluation of graphene oxide on A549 cells. , 2011, Toxicology letters.

[129]  K. Jain,et al.  Advances in the field of nanooncology , 2010, BMC medicine.

[130]  Zhouyi Guo,et al.  Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. , 2011, Biomaterials.

[131]  J. Abrahams,et al.  Ultra-small graphene oxide functionalized with polyethylenimine (PEI) for very efficient gene delivery in cell and zebrafish embryos , 2012, Nano Research.

[132]  Kian Ping Loh,et al.  The chemistry of graphene , 2010 .

[133]  Klaus Kern,et al.  Atomic structure of reduced graphene oxide. , 2010, Nano letters.

[134]  Minghong Wu,et al.  Hydrothermal Route for Cutting Graphene Sheets into Blue‐Luminescent Graphene Quantum Dots , 2010, Advanced materials.

[135]  B. K. Gupta,et al.  Graphene quantum dots derived from carbon fibers. , 2012, Nano letters.

[136]  R. Duncan,et al.  Nanomedicine(s) under the microscope. , 2011, Molecular pharmaceutics.

[137]  D. Fischer,et al.  Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives , 2005, The journal of gene medicine.

[138]  Imre Dékány,et al.  Evolution of surface functional groups in a series of progressively oxidized graphite oxides , 2006 .

[139]  Yongsheng Chen,et al.  Synthesis and characterization of a graphene–C60 hybrid material , 2009 .

[140]  Zhuoxuan Lu,et al.  Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. , 2011, Small.

[141]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[142]  Xiaojun Cai,et al.  Engineered redox-responsive PEG detachment mechanism in PEGylated nano-graphene oxide for intracellular drug delivery. , 2012, Small.

[143]  H. Chae,et al.  Tunable photoluminescence of graphene oxide from near-ultraviolet to blue , 2012 .

[144]  Kai Yang,et al.  In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. , 2011, ACS nano.

[145]  R. Hurt,et al.  Antioxidant deactivation on graphenic nanocarbon surfaces. , 2011, Small.

[146]  C. Fan,et al.  Protein corona-mediated mitigation of cytotoxicity of graphene oxide. , 2011, ACS nano.

[147]  Deepthy Menon,et al.  Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene. , 2011, Nanoscale.

[148]  M. Vallet‐Regí,et al.  Cell uptake survey of pegylated nanographene oxide , 2012, Nanotechnology.

[149]  Mauro Ferrari,et al.  Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.

[150]  Zhuang Liu,et al.  Graphene based gene transfection. , 2011, Nanoscale.

[151]  Jie Shan,et al.  Ultrafast photoluminescence from graphene. , 2010, Physical review letters.

[152]  Sara Linse,et al.  Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.

[153]  R. Jain,et al.  Viscous resistance to blood flow in solid tumors: effect of hematocrit on intratumor blood viscosity. , 1989, Cancer research.

[154]  P. Couvreur,et al.  Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.

[155]  Wilson Mok,et al.  Multiscale measurements distinguish cellular and interstitial hindrances to diffusion in vivo. , 2009, Biophysical journal.

[156]  Kazunori Kataoka,et al.  PEGylated Nanoparticles for Biological and Pharmaceutical Applications , 2003 .

[157]  Mauro Ferrari,et al.  Design maps for nanoparticles targeting the diseased microvasculature. , 2008, Biomaterials.

[158]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .

[159]  Robert Langer,et al.  Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. , 2012, ACS nano.

[160]  Kai Yang,et al.  Multimodal Imaging Guided Photothermal Therapy using Functionalized Graphene Nanosheets Anchored with Magnetic Nanoparticles , 2012, Advanced materials.

[161]  I Levchenko,et al.  Single-step synthesis and magnetic separation of graphene and carbon nanotubes in arc discharge plasmas. , 2010, Nanoscale.

[162]  Zhuang Liu,et al.  Nano-graphene oxide for cellular imaging and drug delivery , 2008, Nano research.

[163]  Rachid Belkhou,et al.  Large-area and high-quality epitaxial graphene on off-axis SiC wafers. , 2012, ACS nano.

[164]  Qiyuan He,et al.  Graphene-based materials: synthesis, characterization, properties, and applications. , 2011, Small.

[165]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[166]  Cyrile Deranlot,et al.  Highly efficient spin transport in epitaxial graphene on SiC , 2012 .

[167]  E. Dickerson,et al.  Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[168]  Sandip Niyogi,et al.  Solution properties of graphite and graphene. , 2006, Journal of the American Chemical Society.

[169]  R K Jain,et al.  Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. , 1992, Cancer research.

[170]  S. Banerjee,et al.  Large-Area Synthesis of High-Quality and Uniform Graphene Films on Copper Foils , 2009, Science.

[171]  Vincent M. Rotello,et al.  Array-based sensing of normal, cancerous, and metastatic cells using conjugated fluorescent polymers. , 2010, Journal of the American Chemical Society.

[172]  Xin Huang,et al.  Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity , 2011 .

[173]  Sang-Jae Kim,et al.  Investigation of Raman and photoluminescence studies of reduced graphene oxide sheets , 2012 .

[174]  Paolo A. Netti,et al.  Solid stress inhibits the growth of multicellular tumor spheroids , 1997, Nature Biotechnology.

[175]  S. Stankovich,et al.  Synthesis and exfoliation of isocyanate-treated graphene oxide nanoplatelets , 2006 .

[176]  Thomas Kelly,et al.  In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. , 2009, Nature nanotechnology.

[177]  N. He,et al.  Preparation of graphene quantum dots for bioimaging application. , 2012, Journal of nanoscience and nanotechnology.

[178]  Imre Dékány,et al.  Enhanced acidity and pH-dependent surface charge characterization of successively oxidized graphite oxides , 2006 .

[179]  Rakesh K. Jain,et al.  Pathology: Cancer cells compress intratumour vessels , 2004, Nature.

[180]  H. Maeda,et al.  Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.

[181]  Lin Li,et al.  Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study. , 2011, Chemical communications.

[182]  Bengt Fadeel,et al.  Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. , 2011, Biochimica et biophysica acta.

[183]  S. Economopoulos,et al.  Porphyrin counter anion in imidazolium-modified graphene-oxide , 2010 .

[184]  Kaushal Rege,et al.  Inorganic nanoparticles for cancer imaging and therapy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[185]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.